NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year gross profit growth rate
Percentile
P3
Near historical low
vs 3Y Ago
-3.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -56.91% |
| Q3 2025 | 8.89% |
| Q2 2025 | 17.01% |
| Q1 2025 | 138.93% |
| Q4 2024 | -67.16% |
| Q3 2024 | 0.94% |
| Q2 2024 | 31.85% |
| Q1 2024 | 50.37% |
| Q4 2023 | -26.88% |
| Q3 2023 | -13.65% |
| Q2 2023 | 53.88% |
| Q1 2023 | 62.77% |
| Q4 2022 | 15.57% |
| Q3 2022 | -55.72% |
| Q2 2022 | 164.79% |
| Q1 2022 | -40.47% |
| Q4 2021 | 64.21% |
| Q3 2021 | -14.04% |
| Q2 2021 | 27.19% |
| Q1 2021 | -4.30% |
| Q4 2020 | -55.20% |
| Q3 2020 | 57.95% |
| Q2 2020 | 14.61% |
| Q1 2020 | -14.13% |
| Q4 2019 | 6.60% |
| Q3 2019 | -11.96% |
| Q2 2019 | 15.29% |
| Q1 2019 | -20.06% |
| Q4 2018 | 0.69% |
| Q3 2018 | -0.60% |
| Q2 2018 | -25.55% |
| Q1 2018 | 22.12% |
| Q4 2017 | 67.76% |
| Q3 2017 | -7.15% |
| Q2 2017 | -17.65% |
| Q1 2017 | -18.29% |
| Q4 2016 | 81.61% |
| Q3 2016 | 12.14% |
| Q2 2016 | -17.86% |
| Q1 2016 | 53.95% |